Cut Your Blood Pressure 3

February 2, 2021 updated by: Florian Rader, Cedars-Sinai Medical Center

Telemedicine and the Barbershop Model of Hypertension Care for Black Men

The recently published LA Barbershop in the New England Journal of Medicine (Victor et al. N Engl J Med 2018; 378: 1291-301) solid evidence of the efficacy of a pharmacist-led medication management intervention to reduce blood pressure in black men that patronize barbershops.

One of the most significant logistical inefficiencies of the LA Barbershop Study was the amount of time the pharmacists spent driving for face-to-face visits with participants. On average, each round trip was 40 miles and pharmacists drove 2 hours per day. By using telemedicine, the study team can minimize the number of face-to-face in-person visits and increase pharmacist efficiency by 25%. the study team aim to increase the scalability of our novel, evidence-based barbershop model by addressing this inefficiency with the pilot study.

In the LA Barbershop trial, each participant averaged 7 in-person visits in 6 months. the study team found that the initial in-person visits between the pharmacist, barber, and patron were essential for establishing trust as well as obtaining baseline electrolyte and serum creatinine levels (with our validated point-of-care device, iSTAT). However, once rapport has been established and blood pressure control achieved, the study team postulate that the effect can be maintained remotely with telemedicine. Our data indicate that most patients' can achieve their blood pressure goal in 3 months or less. the study team propose replacing additional in-person visits with telemonitoring (via Skype or FaceTime) at this juncture, provided blood chemistries are stable.

the study team plan to pilot this in 20 patients from 2 to 3 barbershops for 12 months.

Study Overview

Detailed Description

recently published in the New England Journal of Medicine (Victor et al. N Engl J Med 2018; 378: 1291-301) solid evidence of the efficacy of a pharmacist-led medication management intervention to reduce blood pressure in black men that patronize barbershops.

the study enrolled a cohort of 319 hypertensive non-Hispanic black male patrons from 52 black-owned barbershops in Los Angeles County into a cluster-randomized trial in which barbershops (non-traditional health care setting) were assigned to either a pharmacist-led intervention (in which barbers encouraged in-person meetings with pharmacists who then prescribed drug therapy under a collaborative practice agreement with the participants' doctors) or an active control approach (in which barbers encouraged lifestyle modification and doctor appointments).

At 6 months, the mean systolic blood pressure fell by 27.0 mmHg in the intervention group and by 9.3 mmHg in the control group. A blood pressure level of less than 130/80 was achieved in 64% of the participants in the intervention versus 12% of participants in the control group.

the study team are applying for this grant as a first step in transitioning this evidence-based intervention into a scalable program. Specifically, the study team will do a pilotstudy to test whether the impressive effects on blood pressure can be maintained just as well if face-to face meetings are substituted with telemonitoring after blood pressure is at goal. If successful this approach would markedly increase efficiency by increasing the number of patients a single pharmacist can manage.

Non-Hispanic black men have the highest rate of hypertension-related death of any racial, ethnic, or sex group in the United States. Black men have less physician interaction than black women and lower rates of hypertension treatment and control, necessitating community outreach. Because black men with hypertension often have multiple cardiovascular risk factors, marked reductions in blood pressure - if sustained with the use of our approach and then initiated more widely - might reduce the high rates of hypertension-related disability and death among black men in the United States.

The study team want to demonstrate that participants in this pilot can achieve similar blood pressure reduction at 12 months (as compared to those in our previous trial) when telemedicine is substituted for in-person pharmacist visits after 3 months.

Study Type

Interventional

Enrollment (Actual)

10

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Los Angeles, California, United States, 90048
        • Cedars-Sinai Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

35 years to 79 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • Non-Hispanic Black Men
  • Age 35 to 79 years-old
  • Able to give informed consent
  • Long-term/frequent barbershop patronage (>8 haircuts at the same barbershop in the last 12 months)
  • systolic BP ≥140 on 2 different screening days, and complete set of baseline data
  • Each participant should have their own personal smart cell phone with video chat capability (needed for telemedicine)

Exclusion Criteria:

  • Women
  • Men < 35 years old or Men >79 years old
  • Non-black
  • Hispanic Ethnicity
  • New/infrequent patronage (<8 haircuts at same barbershop in last 12 months);
  • Kidney dialysis.
  • Receiving chemotherapy for cancer. Systolic BP <140 at either screening and incomplete baseline data.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Blood Pressure measurement and pharmacy
Blood Pressure measurement performed by barber and Blood pressure measurement and management visits with study pharmacist in person and through Telemedicine.
Blood Pressure monitoring by barber, Blood pressure measurement and management by pharmacist in person and through telemedicine

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Primary Blood Pressure Outcome - Change in Systolic Blood Pressure
Time Frame: 6 months
The Pre-Specified primary outcome was the change in systolic blood pressure from baseline to 6 months follow-up.
6 months
Primary Blood Pressure Outcome - Change in Systolic Blood Pressure
Time Frame: 12 months
The Pre-Specified primary outcome was the change in systolic blood pressure from baseline to 12 months follow-up.
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 1, 2018

Primary Completion (Actual)

April 1, 2020

Study Completion (Actual)

October 15, 2020

Study Registration Dates

First Submitted

October 30, 2018

First Submitted That Met QC Criteria

October 30, 2018

First Posted (Actual)

October 31, 2018

Study Record Updates

Last Update Posted (Actual)

February 4, 2021

Last Update Submitted That Met QC Criteria

February 2, 2021

Last Verified

February 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 54480

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hypertension

Clinical Trials on Blood Pressure measurement and pharmacy

Subscribe